Analyst Activity – BTIG Research Initiates Coverage On NASDAQ:FIXX – Homology Medicines (NASDAQ:FIXX) With a Buy

ME Staff
-
0

Analyst Ratings For NASDAQ:FIXX – Homology Medicines (NASDAQ:FIXX)

Today, BTIG Research initiated coverage on NASDAQ:FIXX – Homology Medicines (NASDAQ:FIXX) with a Buy with a price target of $35.00.

Some recent analyst ratings include

  • 4/24/2018-BTIG Research initiated coverage with a Buy rating.
  • 4/23/2018-Bank of America initiated coverage with a Buy rating.
  • 4/23/2018-Evercore ISI initiated coverage with a Outperform rating.
  • 4/23/2018-Cowen initiated coverage with a Outperform rating.


  • On 4/2/2018 James E Flynn, Insider, bought 1,250,000 with an average share price of $16.00 per share and the total transaction amounting to $20,000,000.00.
  • On 4/2/2018 Vida Ventures, Llc, Major Shareholder, bought 375,000 with an average share price of $16.00 per share and the total transaction amounting to $6,000,000.00.

Recent Trading Activity for NASDAQ:FIXX – Homology Medicines (NASDAQ:FIXX)
Shares of NASDAQ:FIXX – Homology Medicines closed the previous trading session at 20.50 up +0.60 3.02% with shares trading hands.